Hypoglycaemia in patients with hepatocellular carcinoma is not a particularly important clinical entity, as it usually occurs during the terminal stage of the illness. As many as 13% of patients with hepatocellular carcinoma, however, develop hypoglycaemia early in the course of their illness. This latter group of patients show a distinct pattern in their clinical course and pathology.